Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.
about
IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism?Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityA New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone DiseaseThe systemic nature of CKD.Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Why do young people with chronic kidney disease die early?Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism.Effects of chronic sleep deprivation on bone mass and bone metabolism in rats.From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.Magnesium and cardiovascular complications of chronic kidney disease.The role of phosphate in kidney disease.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients.The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting?Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation.Low Dentin Matrix Protein 1 Is Associated With Incident Cardiovascular Events in Peritoneal Dialysis Patients."Osteotropic" Wnt/LRP Signals: High-Wire Artists in a Balancing Act Regulating Aortic Structure and Function.Walking balance is mediated by muscle strength and bone mineral density in postmenopausal women: an observational study.Serum sclerostin: relation with mortality and impact of hemodiafiltration.Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease.
P2860
Q27024703-9AAC1D29-93C8-4945-B9C4-B6008A9EE062Q28081407-6D37EEDA-F890-4411-B18B-F151B356C7A7Q28552810-12329E63-83C8-482C-8740-C6D331EAF166Q30234695-081E04BA-B13A-4744-9BD1-A9BD38A46C50Q30234751-58D81F31-3855-47D4-9194-97CF2B16302EQ34453230-9C3E1BA3-74BA-438A-B2BE-DAC507FA9524Q36432849-D120806A-41E6-4D5C-A11B-1E6C5D12DF11Q36433637-91D11BA8-57FD-48CD-93E2-25C6DCFA9F8FQ37145808-6A31AB12-3E46-4297-8E5B-7D8EB24E6A60Q38367220-399369D3-EA9C-4AFF-8257-D336C5501273Q38473932-2326652D-24C4-4982-9535-839F4844EE6DQ38793054-93A81FEB-3793-4129-A5DE-0958E34CD06AQ38828618-42DA1A2D-EBAC-4012-9AB8-B5BE96BB20B7Q39009566-8BBE374A-E22C-498B-B73F-9F0A123413B6Q39016562-E3296C72-9940-4B09-BF3C-297600153625Q39101623-6B9EF45C-70FC-40EF-BFD7-3BA6A0E1A10EQ40275241-0DF81FD8-6E92-4EE7-95F9-AC050161232DQ40393891-81D6AF55-672F-4059-856E-9E990EB73159Q47248898-A9D7A7B2-C240-4380-85EF-2EB0FE7523C3Q47396102-65978215-6C3C-451F-82F3-D230B3EC2CF9Q48633678-D70C7E8E-AF34-41C4-836C-E0EA5F3ACC8AQ51839321-DF24D9E0-3733-4E81-90DB-321185959CC2Q52382337-F5E69319-70E3-42CD-A220-7414E4C523D7Q53073924-83739F0B-F2D7-4288-8157-06E49CCDBF12Q55476169-A1E18E31-6644-4930-A6B3-9499D135D094
P2860
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@ast
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@en
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@nl
type
label
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@ast
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@en
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@nl
prefLabel
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@ast
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@en
Bone: a new endocrine organ at ...... nd mineral and bone disorders.
@nl
P2093
P1476
Bone: a new endocrine organ at ...... and mineral and bone disorders
@en
P2093
CKD-MBD Working Group of ERA-EDTA
David Goldsmith
Jordi Bover
Marc G Vervloet
Pablo Ureña-Torres
Vincent M Brandenburg
Ziad A Massy
P304
P356
10.1016/S2213-8587(14)70059-2
P577
2014-05-01T00:00:00Z